Comprehensive genomic characterization of squamous cell lung cancers

Nature

Volumn 489, Issue 7417, 2012, Pages 519-525

  Hammerman, Peter S ^a,b   Voet, Doug ^a   Lawrence, Michael S ^a   Voet, Douglas ^a   Jing, Rui ^a   Cibulskis, Kristian ^a   Sivachenko, Andrey ^a   Stojanov, Petar ^a   McKenna, Aaron ^a   Lander, Eric S ^a,c,d   Gabriel, Stacey ^e   Getz, Gad ^a,e   Imielinski, Marcin ^a,d   Helman, Elena ^a   Hernandez, Bryan ^a   Pho, Nam H ^a   Meyerson, Matthew ^a,b,d   Chu, Andy ^f   Hye Chun, Jung E ^f   Mungall, Andy ^f   Pleasance, Erin ^f   Robertson, A Gordon ^f   Sipahimalani, Payal ^f   Stoll, Dominik ^f   Balasundaram, Miruna ^f   Birol, Inanc ^f   Butterfield, Yaron S N ^f   Chuah, Eric ^f   Coope, Robin J N ^f   Corbett, Richard ^f   Dhalla, Noreen ^f   Guin, Ranabir ^f   He, An ^f   Hirst, Carrie ^f   Hirst, Martin ^f   Holt, Robert A ^f   Lee, Darlene ^f   Li, Haiyan I ^f   Mayo, Michael ^f   Moore, Richard A ^f   Mungall, Karen ^f   Nip, Ka Ming ^f   Olshen, Adam ^g   Schein, Jacqueline E ^f   Slobodan, Jared R ^f   Tam, Angela ^f   Thiessen, Nina ^f   Varhol, Richard ^f   Zeng, Thomas ^f   Zhao, Yongjun ^f   Jones, Steven J M ^f   Marra, Marco A ^f   Saksena, Gordon ^a   Cherniack, Andrew D ^a   Schumacher, Stephen E ^a,b   Tabak, Barbara ^a,b   Carter, Scott L ^a   Nguyen, Huy ^a   Onofrio, Robert C ^e   Crenshaw, Andrew ^a   Ardlie, Kristin ^e   Beroukhim, Rameen ^a,b   Winckler, Wendy ^a,e   Protopopov, Alexei ^b,h   Zhang, Jianhua ^b,h   Hadjipanayis, Angela ^d,i   Lee, Semin ^j   Xi, Ruibin ^j   Yang, Lixing ^j   Ren, Xiaojia ^b,d,i   Zhang, Hailei ^a,b   Shukla, Sachet ^a,b   Chen, Peng Chieh ^d,i   Haseley, Psalm ^i,j   Lee, Eunjung ^i,j   Chin, Lynda ^a,b,d,h   Park, Peter J ^i,j,k   Kucherlapati, Raju ^d,i   Socci, Nicholas D ^l   Liang, Yupu ^l   Schultz, Nikolaus ^l   Borsu, Laetitia ^l   Lash, Alex E ^l   Viale, Agnes ^l   Sander, Chris ^l   Ladanyi, Marc ^l   Auman, J Todd ^m,n   Hoadley, Katherine A ^n,o   Wilkerson, Matthew D ⁿ   Shi, Yan ⁿ   Liquori, Christina ⁿ   Meng, Shaowu ⁿ   Li, Ling ⁿ   Turman, Yidi J ⁿ   Topal, Michael D ^n,o   Tan, Donghui ⁿ   Waring, Scot ⁿ   Buda, Elizabeth ⁿ   Walsh, Jesse ⁿ   Jones, Corbin D ⁿ   Mieczkowski, Piotr A ^o   Singh, Darshan ⁿ   Wu, Junyuan ⁿ   Gulabani, Anisha ⁿ   Dolina, Peter ⁿ   Bodenheimer, Tom ⁿ   Hoyle, Alan P ⁿ   Simons, Janae V ⁿ   Soloway, Matthew G ⁿ   Stuart, Joshua ^t   Mose, Lisle E ^o   Jefferys, Stuart R ^o   Balu, Saianand ⁿ   O'Connor, Brian D ⁿ   Chiang, Derek ^n,o   Liu, Jinze ^q   Chiang, Derek Y ^n,o   Hayes, D Neil ^n,o   Perou, Charles M ^n,o   Cope, Leslie ^r   Weisenberger, Daniel ^s   Danilova, Ludmila ^r   Weisenberger, Daniel J ^s   Maglinte, Dennis T ^s   Pan, Fei ^s   Van Den Berg, David J ^s   Triche Jr , Timothy ^s   Herman, James G ^r   Baylin, Stephen B ^r   Laird, Peter W ^s   Noble, Michael ^a   Gehlenborg, Nils ^a,j   DiCara, Daniel ^a   Zhang, Jinhua ^b,h   Wu, Chang Jiun ^b,h   Liu, Spring Yingchun ^a   Zou, Lihua ^a   Lin, Pei ^a   Cho, Juok ^a   Nazaire, Marc Danie ^a   Robinson, Jim ^a   Thorvaldsdottir, Helga ^a   Mesirov, Jill ^a   Sinha, Rileen ^l   Ciriello, Giovanni ^l   Cerami, Ethan ^l   Gross, Benjamin ^l   Jacobsen, Anders ^l   Gao, Jianjiong ^l   Aksoy, B Arman ^l   Weinhold, Nils ^l   Ramirez, Ricardo ^l   Taylor, Barry S ^l   Antipin, Yevgeniy ^l   Reva, Boris ^l   Mo, Qianxing ^l   Seshan, Venkatraman ^l   Paik, Paul K ^l   Akbani, Rehan ^h   Zhang, Nianxiang ^h   Broom, Bradley M ^h   Casasent, Tod ^h   Unruh, Anna ^h   Wakefield, Chris ^h   Cason, R Craig ^h   Baggerly, Keith A ^h   Weinstein, John N ^h   Haussler, David ^t,u   Benz, Christopher C ^v   Stuart, Joshua M ^t   Zhu, Jingchun ^t   Szeto, Christopher ^t   Scott, Gary K ^v   Yau, Christina ^v   Ng, Sam ^t   Goldstein, Ted ^t   Waltman, Peter ^t   Sokolov, Artem ^t   Collisson, Eric ^w   Ellrott, Kyle ^t   Collisson, Eric A ^w   Zerbino, Daniel ^t   Ma, Singer ^t   Craft, Brian ^t   Du, Ying ⁿ   Cabanski, Christopher ⁿ   Walter, Vonn ⁿ   Marron, J S ^x   Liu, Yufeng ⁿ   Wang, Kai ^q   Prins, Jan F ^n,p   Creighton, Chad J ^y   Zhang, Yiqun ^y   Travis, William D ^l   Rekhtman, Natasha ^l   Yi, Joanne ^z   Aubry, Marie Christine ^z   Cheney, Richard ^aa   Dacic, Sanja ^ab   Flieder, Douglas ^ac   Funkhouser, William ^x   Illei, Peter ^ad   Myers, Jerome ^ae   Tsao, Ming Sound ^af   Penny, Robert ^ag   Mallery, David ^ag   Shelton, Troy ^ag   Hatfield, Martha ^ag   Morris, Scott ^ag   Yena, Peggy ^ag   Shelton, Candace ^ag   Sherman, Mark ^ag   Paulauskis, Joseph ^ag   Govindan, Ramaswamy ^ah   Azodo, Ijeoma ^z   Beer, David ^ai   Bose, Ron ^ah   Byers, Lauren A ^h   Carbone, David ^aj   Chang, Li Wei ^ah   Chun, Elizabeth ^f   Ding, Li ^ah   Heymach, John ^h   Ida, Christiane M ^z   Johnson, Bruce ^b   Jurisica, Igor ^ak   Kaufman, Jacob ^aj   Kosari, Farhad ^z   Kwiatkowski, David ^b   Maher, Christopher A ^ah   Pao, William ^aj   Peifer, Martin ^al,am   Robertson, Gordon ^f   Rusch, Valerie ^l   Siegfried, Jill ^an   Sougnez, Carrie ^d,e   Thomas, Roman K ^al,am   Tomaszek, Sandra ^z   Vaske, Charles ^t   Wheeler, David ^y   Wigle, Dennis A ^z   Wilks, Christopher ^s,t   Zhang, Jianjua John ^b,h   Jensen, Mark A ^ao   Sfeir, Robert ^ao   Kahn, Ari B ^ao   Chu, Anna L ^ao   Kothiyal, Prachi ^ao   Wang, Zhining ^ao   Snyder, Eric E ^ao   Pontius, Joan ^ao   Ayala, Brenda ^ao   Backus, Mark ^ao   Walton, Jessica ^ao   Baboud, Julien ^ao   Berton, Dominique L ^ao   Nicholls, Matthew C ^ao   Srinivasan, Deepak ^ao   Raman, Rohini ^ao   Girshik, Stanley ^ao   Kigonya, Peter A ^ao   Alonso, Shelley ^ao   Sanbhadti, Rashmi N ^ao   Barletta, Sean P ^ao   Greene, John M ^ao   Pot, David A ^ao   Bandarchi Chamkhaleh, Bizhan ^af   Boyd, Jeff ^ac   Weaver, Joellen ^ac   Azodo, Ijeoma A ^z   Tomaszek, Sandra C ^z   Yang, Ping ^z   Brock, Malcolm V ^ad   Rogers, Kristen ^ad   Rutledge, Marian ^ad   Brown, Travis ^ad   Lee, Beverly ^ad   Shin, James ^ad   Trusty, Dante ^ad   Dhir, Rajiv ^ap   Siegfried, Jill M ^an   Potapova, Olga ^aq   Fedosenko, Konstantin V ^ar   Zakowski, Maureen ^l   Nemirovich Danchenko, Elena ^aq   Iacocca, Mary V ^as   Brown, Jennifer ^as   Rabeno, Brenda ^as   Czerwinski, Christine ^as   Petrelli, Nicholas ^as   Fan, Zhen ^at   Todaro, Nicole ^at   Eckman, John ^ae   Rathmell, W Kimryn ⁿ   Thorne, Leigh B ⁿ   Huang, Mei ⁿ   Boice, Lori ⁿ   Hill, Ashley ⁿ   Curley, Erin ^ag   Morrison, Carl ^aa   Gaudioso, Carmelo ^aa   Bartlett, John M S ^au   Kodeeswaran, Sugy ^au   Zanke, Brent ^au   Sekhon, Harman ^av   David, Kerstin ^aw   Juhl, Hartmut ^ax   Le, Xuan Van ^ay   Kohl, Bernard ^ay   Thorp, Richard ^ay   Tien, Nguyen Viet ^az   Bang, Nguyen Van ^ba   Sussman, Howard ^bb   Phu, Bui Duc ^ba   Hajek, Richard ^bc   Hung, Nguyen Phi ^bd   Khan, Khurram Z ^ay   Muley, Thomas ^be   Mills Shaw, Kenna R ^bf   Sheth, Margi ^bf   Yang, Liming ^bf   Demchok, John A ^bf   Davidsen, Tanja ^bf   Buetow, Ken ^bf   Eley, Greg ^bf   Ferguson, Martin ^bg   Dillon, Laura A L ^bf   Schaefer, Carl ^bf   Guyer, Mark S ^bh   Ozenberger, Bradley A ^bh   Palchik, Jacqueline D ^bh   Peterson, Jane ^bh   Sofia, Heidi J ^bh   Thomson, Elizabeth ^bh   Johnson, Bruce E ^b   Shen, Ronglai ^l   more..

^a HARVARD UNIVERSITY   (United States)

^b DANA FARBER CANCER INSTITUTE   (United States)

^c MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

^e BROAD INSTITUTE OF MIT AND HARVARD   (United States)

^f BRITISH COLUMBIA CANCER AGENCY   (Canada)

^g UNIVERSITY OF CALIFORNIA   (United States)

^h UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

ⁱ BRIGHAM AND WOMEN S HOSPITAL   (United States)

^j Harvard Medical School Center for Biomedical Informatics   (United States)

^k BOSTON CHILDREN S HOSPITAL   (United States)

^l MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^m University of North Carolina   (United States)

ⁿ UNIVERSITY OF NORTH CAROLINA   (United States)

^o UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^p Brooks Computer Science Building   (United States)

^q UNIVERSITY OF KENTUCKY   (United States)

^r JOHNS HOPKINS UNIVERSITY   (United States)

^s UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^t University of California Santa Cruz   (United States)

^u UNIVERSITY OF CALIFORNIA   (United States)

^v BUCK INSTITUTE FOR RESEARCH ON AGING   (United States)

^w UNIVERSITY OF CALIFORNIA   (United States)

^x UNIVERSITY OF NORTH CAROLINA HOSPITALS   (United States)

^y BAYLOR COLLEGE OF MEDICINE   (United States)

^z MAYO CLINIC   (United States)

^aa ROSWELL PARK CANCER INSTITUTE   (United States)

^ab UNIVERSITY OF PITTSBURGH   (United States)

^ac FOX CHASE CANCER CENTER   (United States)

^ad JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^ae Penrose Hospital   (United States)

^af Princess Margaret Hospital   (Canada)

^ag International Genomics Consortium   (United States)

^ah WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^ai UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^aj VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^ak IBM CANADA LTD   (Canada)

^al UNIVERSITY OF COLOGNE   (Germany)

^am MAX PLANCK INSTITUTE FOR NEUROLOGICAL RESEARCH   (Germany)

^an UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^ao GENERAL DYNAMICS   (United States)

^ap UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^aq Cureline   (United States)

^ar City Clinical Oncology Dispensary   (Russian Federation)

^as HELEN F GRAHAM CANCER CENTER   (United States)

^at St Joseph Medical Center   (United States)

^au ONTARIO INSTITUTE FOR CANCER RESEARCH   (Canada)

^av UNIVERSITY OF OTTAWA   (Canada)

^aw Indivumed GmbH   (Germany)

^ax Indivumed Inc   (United States)

^ay ILSBio LLC   (United States)

^az MINISTRY OF HEALTH   (Viet Nam)

^ba Hue Central Hospital   (Viet Nam)

^bb STANFORD UNIVERSITY MEDICAL CENTER   (United States)

^bc UNIVERSITY OF TEXAS   (United States)

^bd National Cancer Institute   (Viet Nam)

^be UNIVERSITY OF HEIDELBERG   (Germany)

^bf NATIONAL CANCER INSTITUTE   (United States)

^bg MLF Consulting   (United States)

^bh NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 2A; HLA ANTIGEN CLASS 1; KELCH LIKE ECH ASSOCIATED PROTEIN 1; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN P53;

CANCER; CYTOLOGY; DISEASE TREATMENT; ENZYME ACTIVITY; GENETIC ENGINEERING; GENOMICS; MAJOR HISTOCOMPATIBILITY COMPLEX; MEDICINE; MORTALITY; MUTATION; TUMOR;

ARTICLE; CONTROLLED STUDY; COPY NUMBER VARIATION; EPIGENETICS; EXON; GENOMICS; HUMAN; HUMAN TISSUE; LOSS OF FUNCTION MUTATION; LUNG SQUAMOUS CELL CARCINOMA; MAJOR CLINICAL STUDY; PRIORITY JOURNAL;

EID: 84866894408     PISSN: 00280836     EISSN: 14764687     Source Type: Journal    
DOI: 10.1038/nature11404     Document Type: Article

References (46)

1. World Health Organization. Cancer, fact sheet no. 297 Æhttp://www.who.int/mediacentre/factsheets/fs297/en/æ (accessed February 2012).
2. Soda, M. et al. Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer. Nature 448, 561-566 (2007).
3. Paez, J. G. et al. EGFR mutations inlung cancer: correlation with clinical response to gefitinib therapy. Science 304, 1497-1500 (2004).
4. Lynch, T. J. et al. Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib. N. Engl. J. Med. 350, 2129-2139 (2004).
5. Pao, W. et al. EGF receptor gene mutations are common in lung cancers from "never smokers" and are associated with sensitivity of tumors to gefitinib and erlotinib. Proc. Natl Acad. Sci. USA 101, 13306-13311 (2004).
6. Felip, E., Gridelli, C., Baas, P., Rosell, R. & Stahel, R. Metastatic non-small-cell lung cancer: consensus on pathology and molecular tests, first-line, second-line, and third-line therapy. Ann. Oncol. 22, 1507-1519 (2011).
7. Ju, Y. S. et al. A transforming KIF5B and RET gene fusion in lung adenocarcinoma revealed from whole-genome and transcriptome sequencing. Genome Res. 22, 436-445 (2012).
8. Rekhtman, N. et al. Clarifying the spectrum of driver oncogene mutations in biomarker-verified squamous carcinoma of lung: lack of EGFR/KRAS and presence of PIK3CA/AKT1 mutations. Clin. Cancer. Res. 18, 1167-1176 (2012).
9. Bass, A. J. et al. SOX2 is an amplified lineage-survival oncogene in lung and esophageal squamous cell carcinomas. Nature Genet. 41, 1238-1242 (2009).
10. Ramos, A. H. et al. Amplification of chromosomal segment 4q12 in non-small cell lung cancer. Cancer Biol. Ther. 8, 2042-2050 (2009).
11. Shibata, T. et al. Cancer related mutationsinNRF2 impair its recognition byKeap1-Cul3 E3 ligase and promote malignancy. Proc. Natl Acad. Sci. USA 105, 13568-13573 (2008).
12. Kan, Z. et al. Diverse somatic mutation patterns and pathway alterationsinhuman cancers. Nature 466, 869-873 (2010).
13. Hammerman, P. S., Sos, M. L., Ramos, A. & Xu, C. Mutations in the DDR2 kinase gene identify a novel therapeutic target in squamous cell lung cancer. Cancer Discovery 1, 78 (2011).
14. Weiss, J. et al. Frequent and focal FGFR1 amplification associates with therapeutically tractable FGFR1 dependency in squamous cell lung cancer. Sci. Transl. Med. 2, 62ra93 (2010).
15. Dutt, A. et al. Inhibitor-sensitive FGFR1 amplification in human non-small cell lung cancer. PLoS One 6, e20351 (2011).
16. Kenfield, S. A., Wei, E. K., Stampfer, M. J., Rosner, B. A. & Colditz, G. A. Comparison of aspects of smoking among the four histological types of lung cancer. Tob. Control 17, 198-204 (2008).
17. The Cancer Genome Atlas Research Network. Integrated genomic analyses of ovarian carcinoma. Nature 474, 609-615 (2011).
18. The Cancer Genome Atlas Research Network. Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature 455, 1061-1068 (2008).
19. Tonon, G. et al. High-resolution genomic profiles of human lung cancer. Proc. Natl Acad. Sci. USA 102, 9625-9630 (2005).
20. Beroukhim, R. et al. The landscape of somatic copy-number alteration across human cancers. Nature 463, 899-905 (2010).
21. Mermel, C. H. et al. GISTIC2. 0 facilitates sensitive and confident localization of the targets of focal somatic copy-number alteration in human cancers. Genome Biol. 12, R41 (2011).
22. Stransky, N. et al. The mutational landscape of head and neck squamous cell carcinoma. Science 333, 1157-1160 (2011).
23. Chapman, M. A. et al. Initial genome sequencingandanalysisofmultiple myeloma. Nature 471, 467-472 (2011).
24. Agrawal, N. et al. Exome sequencing of head and neck squamous cell carcinoma reveals inactivating mutations in NOTCH1. Science 333, 1154-1157 (2011).
25. Bass, A. J. et al. Genomic sequencing of colorectal adenocarcinomas identifies a recurrent VTI1A-TCF7L2 fusion. Nature Genet. 43, 964-968 (2011).
26. Berger, M. F. et al. The genomic complexity of primary human prostate cancer. Nature 470, 214-220 (2011).
27. Stephens, P. J. et al. Complex landscapes of somatic rearrangement in human breast cancer genomes. Nature 462, 1005-1010 (2009).
28. Singh, A. et al. Dysfunctional KEAP1-NRF2 interaction in non-small-cell lung cancer. PLoS Med. 3, e420 (2006).
29. Singh, A., Bodas, M., Wakabayashi, N., Bunz, F. & Biswal, S. Gain of Nrf2 function in non-small-cell lung cancer cells confers radioresistance. Antioxid. Redox Signal. 13, 1627-1637 (2010).
30. Vaske, C. J. et al. Inference of patient-specific pathway activities from multidimensional cancer genomics data using PARADIGM. Bioinformatics 26, i237-i245 (2010).
31. Aster, J. C., Blacklow, S. C. & Pear, W. S. Notch signalling in T-cell lymphoblastic leukaemia/lymphoma and other haematological malignancies. J. Pathol. 223, 263-274 (2011).
32. Wang, N. J. et al. Loss-of-function mutations in Notch receptors in cutaneous and lung squamous cell carcinoma. Proc. Natl Acad. Sci. USA 108, 17761-17766 (2011).
33. Osada, H., Tatematsu, Y., Yatabe, Y., Horio, Y. & Takahashi, T. ASH1geneisa specific therapeutic target for lung cancers with neuroendocrine features. Cancer Res. 65, 10680-10685 (2005).
34. Wilkerson, M. D. et al. Lung squamous cell carcinoma mRNA expression subtypes are reproducible, clinically important, and correspond to normal cell types. Clin. Cancer Res. 16, 4864-4875 (2010).
35. Bishop, J. A. et al. p40 (DNp63) is superior to p63 for the diagnosis of pulmonary squamous cell carcinoma. Mod. Pathol. 25, 405-415 (2011).
36. Massion, P. P. et al. Significance of p63 amplification and overexpression in lung cancer development and prognosis. Cancer Res. 63, 7113-7121 (2003).
37. Shen, R., Olshen, A. B. & Ladanyi, M. Integrative clustering ofmultiple genomic data types using a joint latent variable model with application tobreast and lung cancer subtype analysis. Bioinformatics 25, 2906-2912 (2009).
38. Wikman, H. & Kettunen, E. Regulation of the G1/S phase of the cell cycle and alterationsintheRBpathwayinhuman lung cancer. Expert Rev. Anticancer Ther. 6, 515-530 (2006).
39. Kancha, R. K., Peschel, C. & Duyster, J. The epidermal growth factor receptor-L861Q mutation increases kinase activity without leading to enhanced sensitivity toward epidermal growth factor receptor kinase inhibitors. J. Thorac. Oncol. 6, 387-392 (2011).
40. Reva, B., Antipin, Y. & Sander, C. Predicting the functional impact of protein mutations: application to cancer genomics. Nucleic Acids Res. 39, e118 (2011).
41. Govindan, R. Summary of the proceedings from the 10th annual meeting of molecularly targeted therapy in non-small cell lung cancer. J. Thorac. Oncol. 5, S433 (2010).
42. Ding, L. et al. Somatic mutations affect key pathways in lung adenocarcinoma. Nature 455, 1069-1075 (2008).
43. Ciriello, G., Cerami, E., Sander, C. & Schultz, N. Mutual exclusivity analysis identifies oncogenic network modules. Genome Res. 22, 398-406 (2012).
44. Hanahan, D. & Weinberg, R. A. Hallmarks of cancer: the next generation. Cell 144, 646-674 (2011).
45. Brahmer, J. R. et al. Phase Istudyofsingle-agent anti-programmed death-1(MDX-1106) in refractory solid tumors: safety, clinical activity, pharmacodynamics, and immunologic correlates. J. Clin. Oncol. 28, 3167-3175 (2010).
46. Lynch, T. J. et al. Phase II trial of ipilimumab (IPI) and paclitaxel/carboplatin (P/C) in first-line stage IIIb/IV non-small cell lung cancer (NSCLC). J. Clin. Oncol. 28, 7531 (2010).